Humacyte, Inc.HUMANASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
15.74%
↑ 280% above average
Average (5y)
4.14%
Historical baseline
Range
High:21.01%
Low:-28.47%
Volatility
1195.3%
High variability
| Period | Value |
|---|---|
| 2024 | 15.74% |
| 2023 | 21.01% |
| 2022 | 3.13% |
| 2021 | 13.43% |
| 2020 | -28.47% |
| 2019 | 0.00% |